References
- Cazals Y. Auditory sensori-neural alterations induced by salicylate. Prog Neurobiol 2000; 62: 583–631
- Lue AJ, Brownell WE. Salicylate induced changes in outer hair cell lateral wall stiffness. Hear Res 1999; 135: 163–8
- Didier A, Miller JM, Nuttall AL. The vascular component of sodium salicylate ototoxicity in the guinea pig. Hear Res 1993; 69: 199–206
- Stypulkowski PH. Mechanisms of salicylate ototoxicity. Hear Res 1990; 46: 113–45
- Jung TT, Hwang AL, Miller SK, Rhee CK, Park YS. Effect of leukotriene inhibitor on cochlear blood flow in salicylate ototoxicity. Acta Otolaryngol 1995; 115: 251–4
- Heller S. Molecular screens for inner ear genes. J Neurobiol 2002; 53: 265–75
- Robertson NG, Skvorak AB, Yin Y, Weremowicz S, Johnson KR, Kovatch KA, et al. Mapping and characterization of a novel cochlear gene in human and in mouse: a positional candidate gene for a deafness disorder, DFNA9. Genomics 1997; 46: 345–54
- Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, et al. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 1992; 70: 31–46
- Mohn AR, Feddersen RM, Nguyen MS, Koller BH. Phenotypic analysis of mice lacking the highly abundant Purkinje cell- and bipolar neuron-specific PCP2 protein. Mol Cell Neurosci 1997; 9: 63–76
- Hashimoto M, Koda M, Ino H, Yoshinaga K, Murata A, Yamazaki M, et al. Gene expression profiling of cathepsin D, metallothioneins-1 and -2, osteopontin, and tenascin-C in a mouse spinal cord injury model by cDNA microarray analysis. Acta Neuropathol (Berl) 2005; 109: 165–80
- Horie M, Mitsumoto Y, Kyushiki H, Kanemoto N, Watanabe A, Taniguchi Y, et al. Identification and characterization of TMEFF2, a novel survival factor for hippocampal and mesencephalic neurons. Genomics 2000; 67: 146–52
- Merchan-Perez A, Gil-Loyzaga P, Eybalin M. Ontogeny of glutamate decarboxylase and gamma-aminobutyric acid immunoreactivities in the rat cochlea. Eur Arch Otorhinolaryngol 1990; 248: 4–7
- Osei YD, Churchich JE. Screening and sequence determination of a cDNA encoding the human brain 4-aminobutyrate aminotransferase. Gene 1995; 155: 185–7
- Kirkpatrick LL, Matzuk MM, Dodds DC, Perin MS. Biochemical interactions of the neuronal pentraxins. Neuronal pentraxin (NP) receptor binds to taipoxin and taipoxin-associated calcium-binding protein 49 via NP1 and NP2. J Biol Chem 2000; 275: 17786–92
- Brabet P, Diriong S, Journot L, Bockaert J, Taviaux S. Localization of the human pituitary adenylate cyclase-activating polypeptide receptor (PACAP1-R) gene to 7p15-p14 by fluorescence in situ hybridization. Genomics 1996; 38: 100–2
- Kadota Y, Niiya A, Masaki R, Yamamoto A, Araki M, Taketani S. A newly identified membrane protein localized exclusively in intracellular organelles of neurons. Brain Res Mol Brain Res 1997; 46: 265–73
- O'Dowd BF, Nguyen T, Lynch KR, Kolakowski LF, Jr, Thompson M, Cheng R, et al. A novel gene codes for a putative G protein-coupled receptor with an abundant expression in brain. FEBS Lett 1996; 394: 325–9
- Singec I, Knoth R, Ditter M, Hagemeyer CE, Rosenbrock H, Frotscher M, et al. Synaptic vesicle protein synaptoporin is differently expressed by subpopulations of mouse hippocampal neurons. J Comp Neurol 2002; 452: 139–53
- Fukuda M, Mikoshiba K. Characterization of KIAA1427 protein as an atypical synaptotagmin (Syt XIII). Biochem J 2001; 354: 249–57
- Nesbit MA, Hodges MD, Campbell L, de Meulemeester TM, Alders M, Rodrigues NR, et al. Genomic organization and chromosomal localization of a member of the MAP kinase phosphatase gene family to human chromosome 11p15.5 and a pseudogene to 10q11.2. Genomics 1997; 42: 284–94
- Edelhoff S, Villacres EC, Storm DR, Disteche CM. Mapping of adenylyl cyclase genes type I, II, III, IV, V, and VI in mouse. Mamm Genome 1995; 6: 111–13
- Jiang M, Zhang M, Tang DG, Clemo HF, Liu J, Holwitt D, et al. KCNE2 protein is expressed in ventricles of different species, and changes in its expression contribute to electrical remodeling in diseased hearts. Circulation 2004; 109: 1783–8
- Morishita Y, Sakube Y, Sasaki S, Ishibashi K. Molecular mechanisms and drug development in aquaporin water channel diseases: aquaporin superfamily (superaquaporins): expansion of aquaporins restricted to multicellular organisms. J Pharmacol Sci 2004; 96: 276–79
- Kasting NW, Martin JB. Endogenous prostaglandins affect growth hormone and thyrotropin release at a hypothalamic, not a pituitary level. Neuroendocrinology 1984; 39: 201–5
- Kitajiri SI, Furuse M, Morita K, Saishin-Kiuchi Y, Kido H, Ito J, et al. Expression patterns of claudins, tight junction adhesion molecules, in the inner ear. Hear Res 2004; 187: 25–34